Canada approved Amylyx Pharmaceuticals Inc.’s caller cause for amyotrophic lateral sclerosis past week. Now immoderate U.S. patients with the fatal neurodegenerative disorder—also known arsenic Lou Gehrig’s disease—are considering a travel northbound to get the medication, Albrioza. The cause isn’t approved successful the U.S.
William Woods, a 75-year-old retired doc successful Atlanta who was diagnosed with ALS successful 2019, is contacting Canadian doctors who mightiness assistance him get Albrioza. “There is simply a batch to fig out,” helium said, “but I americium assured I volition find idiosyncratic I tin spell see.”